CIK: 1685138 - Address: The Lennox Building, 50 Richmond Street South, Dublin, Ireland, L2 D02 FK02
8 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

P%ret111-4-11-716-750-16
P%wins000100020

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

8/10/22 20:49
8/8/22
PSTXPoseida Therapeutics, Inc.HealthBioPrdBiological Products, (No DiagMalin Life Sciences Holdings LtdL2TP7,5253.5002,1502211,836D
12/7/21 06:03
12/6/21
PSTXPoseida Therapeutics, Inc.HealthBioPrdBiological Products, (No DiagMalin Life Sciences Holdings LtdL2THCommon dP136.900209,686D
12/2/21 18:33
11/30/21
PSTXPoseida Therapeutics, Inc.HealthBioPrdBiological Products, (No DiagMalin Life Sciences Holdings LtdL2THCommon dP.m3516.8505119,684D
11/29/21 19:55
11/24/21
PSTXPoseida Therapeutics, Inc.HealthBioPrdBiological Products, (No DiagMalin Life Sciences Holdings LtdL2THCommon dP.m2696.8303909,633D
11/23/21 18:41
11/19/21
PSTXPoseida Therapeutics, Inc.HealthBioPrdBiological Products, (No DiagMalin Life Sciences Holdings LtdL2THCommon dP.m1827.0602609,593D
11/18/21 20:24
11/16/21
PSTXPoseida Therapeutics, Inc.HealthBioPrdBiological Products, (No DiagMalin Life Sciences Holdings LtdL2THCommon dP.m2,7327.20037949,568D
7/2/19 21:45
6/28/19
NOVNNovan, Inc.DEHealthDrugPharmaceutical PreparationsMalin Life Sciences Holdings LtdL2TS.m-682.710-25-12,598I
9/28/16 18:27
9/26/16
NOVNNovan, Inc.DEHealthDrugPharmaceutical PreparationsMalin Life Sciences Holdings LtdL2TP.d8,80011.0018800442,623I4-4-11-716-75

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact